IMMUNOHISTOCHEMISTRY, ACTIN (SMOOTH MUSCLE ACTIN)

The IHC – Actin (Smooth Muscle Actin / SMA) test is an immunohistochemistry-based diagnostic assay used to detect smooth muscle actin protein expression in tissue samples. Smooth Muscle Actin is a structural protein commonly found in smooth muscle cells and myofibroblasts, making it an important marker in pathology for identifying smooth muscle differentiation.

This test is widely used in the diagnosis and classification of smooth muscle tumors, myofibroblastic lesions, and certain soft tissue neoplasms. SMA staining helps pathologists determine whether a tumor originates from smooth muscle tissue and assists in differentiating benign and malignant lesions.

Benefits of the Test

• Helps diagnose smooth muscle tumors
• Assists in identifying myofibroblastic lesions
• Supports classification of soft tissue tumors
• Improves tumor differentiation accuracy
• Helps guide oncology treatment planning

Why Doctors Recommend This Test

Doctors recommend the IHC SMA test when there is suspicion of smooth muscle or soft tissue tumors. It is commonly used in:

• Diagnosis of leiomyoma and leiomyosarcoma
• Evaluation of spindle cell tumors
• Identification of myofibroblastic proliferation
• Soft tissue tumor classification
• Oncology biopsy interpretation

SMA is frequently used along with other markers such as Desmin, H-Caldesmon, Vimentin, and S100 for precise tumor identification and classification.

Preparation Before Test

No special preparation is required from the patient. Important considerations include:

• The test is performed on a biopsy or surgical tissue sample
• No fasting or medication restrictions are necessary
• Clinical history and imaging findings may assist interpretation

Normal Reporting Time

The typical turnaround time is 3 to 5 working days, depending on laboratory workflow and tissue processing complexity.

Who Should Take This Test

• Patients with suspected smooth muscle tumors
• Individuals with soft tissue masses of unknown origin
• Cases requiring spindle cell tumor evaluation
• Patients undergoing biopsy for tumor classification
• Oncology patients requiring immunohistochemistry profiling

The IHC Smooth Muscle Actin (SMA) test is an important diagnostic tool in surgical pathology and oncology. By identifying smooth muscle differentiation in tissue samples, it helps clinicians accurately diagnose soft tissue tumors and plan effective treatment strategies.